Cereno Scientific AB
Cereno Scientific are active within biotechnology. Today, the company is focused on developing pharmaceuticals for the treatment of various cardiovascular diseases. The products are used to treat potential blood clots that may lead to stroke, myocardial infarction, pulmonary embolism, as well as venous thrombosis. The company was founded in 2012 and is based in Mölndal.
Quotes
Board
CEO
- Sten Sörensen
Chairperson of the Board
- Joakim Söderström
Board
- Anders Svensson
- Jonas Faijerson Säljö
- Lena Mårtensson
- Sverker Jern
*Powered by Modular Finance